On 1 June 2020, 6 million cases of COVID-19 were recorded with a total of 374,927 deaths worldwide. Brazil, at that point, presented a total of 514,992 cases and 29,341 deaths caused by the COVID-19 disease. At that moment, Brazil appeared in the second position regarding number of cases, fourth in number of deaths, second in number of recovered patients (N = 206,555), second in number of follow-up cases (N = 279,096), third in number of active and serious cases (N = 8,318), 39^th in number of cases per million inhabitants (N = 2,424), and 125^th in number of SARS-CoV-2 real-time polymerase chain reaction (RT-PCR) exams per million inhabitants (N = 4,378). To beat the pandemic, Brazil needs to optimize the COVID-19 diagnosis through the SARS-CoV-2 identification using RT-PCR tests and adjust its policies to save lives. Brazil is in a crucial moment to minimize the impact of the illness on society by reducing the number of new cases and thus, preventing deaths, mainly of the risk group populations. However, as widely announced, in Brazil the diagnosis using RT-PCR is still scarce and part of the material collected from COVID-19 patients was disposed of and many patients were not tested, regardless of the seriousness of the symptoms, due to errors of medical data records, improper conservation of the samples after collection and/or during transport, which compromised the quality of the material to be tested. Moreover, the federal government has supported the end of the quarantine, while the number of deaths has grown in thousands every day and the cases have been expanding to the interior of the country.

到2020年6月1日，全球记录了600万例COVID-19病例，死亡374,927人。到那时，巴西共报告了514,992例病例，其中有29,341例是由COVID-19疾病引起的死亡。当时，巴西的病例数位居第二，死亡人数排在第四位，康复患者数排在第二位（N = 206,555），随访病例数排在第二位（N = 279,096），第三位。的活性和严重的情况下（N = 8318），39^个在每百万居民病例数（N = 2424），和125^个每百万居民SARS-CoV-2实时聚合酶链反应（RT-PCR）考试的数量（N = 4,378）。为了战胜这种大流行，巴西需要通过使用RT-PCR测试的SARS-CoV-2鉴定来优化COVID-19诊断，并调整其政策以挽救生命。巴西正处于关键时刻，要通过减少新病例的数量来减少疾病对社会的影响，从而防止死亡，主要是危险人群的死亡。但是，正如广泛宣布的那样，在巴西，使用RT-PCR的诊断仍然很少，并且从COVID-19患者那里收集的部分材料已被处理掉，并且由于症状的严重性，无论症状的严重性，都没有对许多患者进行测试。医疗数据记录，样品在收集后和/或运输过程中的不当保存，这损害了要测试的材料的质量。此外，联邦政府支持隔离的结束，而死亡人数每天增加成千上万，案件正在扩大到该国内部。